Immunologic applications of conditional gene modification technology in the mouse

Current Protocols in Immunology

Volumn , Issue SUPPL.105, 2014, Pages

  Sharma, Suveena ^a   Zhu, Jinfang ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Bacterial artificial chromosome (BAC); Conditional knockout; Cre; Fate mapping; Hematopoietic cells; Inducible gene expression; LoxP; Lymphocyte cell development and differentiation; Transgenic

Indexed keywords

CRE RECOMBINASE; INTEGRASE;

ARTICLE; CELL FATE; CELL LINEAGE; DNA MODIFICATION; ENZYME ACTIVITY; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; IMMUNOCOMPETENT CELL; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; TISSUE SPECIFICITY; TRANSGENIC MOUSE; ANIMAL; ANTIBODY SPECIFICITY; GENE SILENCING; GENETICS; MOUSE; PROCEDURES;

ANIMALS; GENE DELETION; GENE KNOCKDOWN TECHNIQUES; INTEGRASES; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY;

EID: 84940235360     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1034s105     Document Type: Article

References (78)

1. Aghajani, K., Keerthivasan, S., Yu, Y., and Gounari, F. 2012. Generation of CD4CreER(T(2)) transgenic mice to study development of peripheral CD4-T-cells. Genesis 50:908-913.
2. Anastassiadis, K., Fu, J., Patsch, C., Hu, S., Weidlich, S., Duerschke, K., Buchholz, F., Edenhofer, F., and Stewart, A.F. 2009. Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis. Model Mech. 2:508-515.
3. Baron, U. and Bujard, H. 2000. Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances. Methods Enzymol. 327:401-421.
4. Belteki, G., Haigh, J., Kabacs, N., Haigh, K., Sison, K., Costantini, F., Whitsett, J., Quaggin, S.E., and Nagy, A. 2005. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 33:e51.
5. Bockamp, E.,Maringer, M., Spangenberg, C., Fees, S., Fraser, S., Eshkind, L., Oesch, F., and Zabel, B. 2002. Of mice and models: Improved animal models for biomedical research. Physiol. Genomics 11:115-132.
6. Boross, P., Breukel, C., van Loo, P.F., van der Kaa, J., Claassens, J.W., Bujard, H., Schönig, K., and Verbeek, J.S. 2009. Highly B lymphocytespecific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector. Genesis 47:729-735.
7. Branda, C.S. and Dymecki, S.M. 2004. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 6:7-28.
8. Brocard, J., Warot, X., Wendling, O., Messaddeq, N., Vonesch, J.L., Chambon, P., and Metzger, D. 1997. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc. Natl. Acad. Sci. U.S.A. 94:14559-14563.
9. Buch, T., Heppner, F.L., Tertilt, C., Heinen, T.J., Kremer, M., Wunderlich, F.T., Jung, S., and Waisman, A. 2005. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2:419- 426.
10. Capecchi, M.R. 1989a. Altering the genome by homologous recombination. Science 244:1288- 1292.
11. Capecchi, M.R. 1989b. The new mouse genetics: Altering the genome by gene targeting. Trends Genet. 5:70-76.
12. Carlson, D.F., Fahrenkrug, S.C., and Hackett, P.B. 2012. TargetingDNAwith fingers and TALENs. Mol. Ther. Nucleic Acids 1:e3.
13. Caton, M.L., Smith-Raska, M.R., and Reizis, B. 2007. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204:1653-1664.
14. Clausen, B.E., Burkhardt, C., Reith,W., Renkawitz, R., and Forster, I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265-277.
15. de Boer, J., Williams, A., Skavdis, G., Harker, N., Coles, M., Tolaini, M., Norton, T., Williams, K., Roderick, K., Potocnik, A.J., and Kioussis, D. 2003. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33:314-325.
16. Donnelly, M.L., Luke, G., Mehrotra, A., Li, X., Hughes, L.E., Gani, D., and Ryan, M.D. 2001. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: A putative ribosomal 'skip'. J. Gen. Virol. 82:1013-1025.
17. Dymecki, S.M. 1996a. A modular set of Flp, FRT and lacZ fusion vectors for manipulating genes by site-specific recombination. Gene 171:197- 201.
18. Dymecki, S.M. 1996b. Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc.Natl. Acad. Sci. U.S.A. 93:6191-6196.
19. Evans, M.J. and Kaufman, M.H. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
20. Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., and Chambon, P. 1996. Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. U.S.A. 93: 10887-10890.
21. Felsher, D.W. andBishop, J.M. 1999. Reversible tumorigenesis byMYCin hematopoietic lineages. Mol. Cell 4:199-207.
22. Fiering, S., Epner, E., Robinson, K., Zhuang, Y., Telling, A., Hu, M.,Martin, D.I., Enver, T., Ley, T.J., and Groudine, M. 1995. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev. 9:2203- 2213.
23. Gossen, M. and Bujard, H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89:5547-5551.
24. Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen,W., and Bujard, H. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769.
25. Groth, A.C., Fish, M., Nusse, R., and Calos, M.P. 2004. Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics 166:1775-1782.
26. Gu, H., Zou, Y.R., and Rajewsky, K. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164.
27. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H., andRajewsky, K. 1994. Deletion of aDNApolymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265:103- 106.
28. Hamilton, D.L. and Abremski, K. 1984. Sitespecific recombination by the bacteriophage P1 lox-Cre system: Cre-mediated synapsis of two lox sites. J. Mol. Biol. 178:481-486.
29. Hartung, M. and Kisters-Woike, B. 1998. Cre mutants with altered DNA binding properties. J. Biol. Chem. 273:22884-22891.
30. Hobeika, E., Thiemann, S., Storch, B., Jumaa, H., Nielsen, P.J., Pelanda, R., and Reth, M. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. U.S.A. 103:13789-13794.
31. Hoess, R.H. and Abremski, K. 1985. Mechanism of strand cleavage and exchange in the Cre-lox site-specific recombination system. J. Mol. Biol. 181:351-362.
32. Hoess, R.H., Ziese, M., and Sternberg, N. 1982. P1 site-specific recombination: Nucleotide sequence of the recombining sites. Proc. Natl. Acad. Sci. U.S.A. 79:3398-3402.
33. Indra, A.K., Warot, X., Brocard, J., Bornert, J.M., Xiao, J.H., Chambon, P., and Metzger, D. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifeninducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 27:4324-4327.
34. Ivanova, A., Signore, M., Caro, N., Greene, N.D., Copp, A.J., and Martinez-Barbera, J.P. 2005. In vivo genetic ablation by Cre-mediated expression of diphtheria toxin fragment A. Genesis 43:129-135.
35. Jacob, J. and Baltimore, D. 1999. Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399:593-597.
36. Keravala, A. and Calos, M.P. 2008. Site-specific chromosomal integration mediated by phiC31 integrase. Methods Mol. Biol. 435:165-173.
37. Klinger, M., Kim, J.K., Chmura, S.A., Barczak, A., Erle, D.J., and Killeen, N. 2009. Thymic OX40 expression discriminates cells undergoing strong responses to selection ligands. J. Immunol. 182:4581-4589.
38. Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. 1995. Inducible gene targeting in mice. Science 269:1427-1429.
39. Lakso, M., Pichel, J.G., Gorman, J.R., Sauer, B., Okamoto, Y., Lee, E., Alt, F.W., and Westphal, H. 1996. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. U.S.A. 93:5860-5865.
40. Lee, P.P., Fitzpatrick, D.R., Beard, C., Jessup, H.K., Lehar, S., Makar, K.W., Pérez-Melgosa, M., Sweetser, M.T., Schlissel, M.S., Nguyen, S., Cherry, S.R., Tsai, J.H., Tucker, S.M., Weaver, W.M., Kelso, A., Jaenisch, R., andWilson, C.B. 2001.Acritical role forDnmt1 andDNAmethylation in T cell development, function, and survival. Immunity 15:763-774.
41. Loonstra, A., Vooijs, M., Beverloo, H.B., Allak, B.A., van Drunen, E., Kanaar, R., Berns, A., and Jonkers, J. 2001. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 98:9209-9214.
42. Madisen, L., Zwingman, T.A., Sunkin, S.M., Oh, S.W., Zariwala, H.A.,Gu, H.,Ng, L.L., Palmiter, R.D., Hawrylycz, M.J., Jones, A.R., Lein, E.S., and Zeng, H. 2010. A robust and highthroughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13:133-140.
43. Maekawa, Y.,Minato, Y., Ishifune, C., Kurihara, T., Kitamura, A., Kojima, H., Yagita, H., Sakata- Yanagimoto, M., Saito, T., Taniuchi, I., Chiba, S., Sone, S., and Yasutomo, K. 2008. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat. Immunol. 9:1140-1147.
44. Mao, X., Fujiwara, Y., and Orkin, S.H. 1999. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. U.S.A. 96:5037-5042.
45. Metzger, D., Clifford, J., Chiba, H., and Chambon, P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. U.S.A. 92:6991-6995.
46. Nagy, A. 2000. Cre recombinase: The universal reagent for genome tailoring. Genesis 26:99- 109.
47. Nagy, A.,Mar, L., andWatts,G. 2009. Creation and use of a cre recombinase transgenic database. Methods Mol. Biol. 530:365-378.
48. Novak, A., Guo, C., Yang, W., Nagy, A., and Lobe,C.G. 2000. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28:147-155.
49. Rajewsky,K., Gu,H.,Kühn, R., Betz, U.A.,Müller, W., Roes, J., and Schwenk, F. 1996. Conditional gene targeting. J. Clin. Invest. 98:600-603.
50. Rawlins, E.L., Clark, C.P., Xue, Y., and Hogan, B.L. 2009. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 136:3741-3745.
51. Rickert, R.C., Roes, J., and Rajewsky, K.B. 1997. Lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1317-1318.
52. Rodriguez, C.I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., Stewart, A.F., and Dymecki, S.M. 2000. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25:139-140.
53. Rohlmann, A., Gotthardt, M., Willnow, T.E., Hammer, R.E., and Herz, J. 1996. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat. Biotechnol. 14:1562-1565.
54. Rubtsov, Y.P., Rasmussen, J.P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson,W.R. Jr., Muller,W., and Rudensky, A.Y. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:546-558.
55. Rubtsov, Y.P., Niec, R.E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., and Rudensky, A.Y. 2010. Stability of the regulatory T cell lineage in vivo. Science 329:1667-1671.
56. Ryan, M.D., King, A.M., and Thomas, G.P. 1991. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 72:2727-2732.
57. Sauer, B. 1998. Inducible gene targeting in mice using the Cre/lox system. Methods 14:381-392.
58. Sauer, B. and Henderson, N. 1998. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. U.S.A. 85:5166-5170.
59. Schwenk, F., Baron, U., and Rajewsky, K. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:5080-5081.
60. Seibler, J., Zevnik, B., Küter-Luks, B., Andreas, S., Kern, H., Hennek, T., Rode, A., Heimann, C., Faust, N., Kauselmann, G., Schoor, M., Jaenisch, R., Rajewsky, K., Kühn, R., and Schwenk, F. 2003. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 31:e12.
61. Shaikh, A.C. and Sadowski, P.D. 2000. Chimeras of the Flp and Cre recombinases: Tests of the mode of cleavage by Flp and Cre. J. Mol. Biol. 302:27-48.
62. Shimshek, D.R., Kim, J., Hübner, M.R., Spergel, D.J., Buchholz, F., Casanova, E., Stewart, A.F., Seeburg, P.H., and Sprengel, R. 2002. Codonimproved Cre recombinase (iCre) expression in the mouse. Genesis 32:19-26.
63. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70-71.
64. Soukharev, S., Miller, J.L., and Sauer, B. 1999. Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res. 27:e21.
65. Srinivas, S.,Watanabe, T., Lin, C.S.,William, C.M., Tanabe, Y., Jessell, T.M., and Costantini, F. 2001. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1:4.
66. Stec, D.E., Davisson, R.L., Haskell, R.E., Davidson, B.L., and Sigmund, C.D. 1999. Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre recombinase in vivo. J. Biol. Chem. 274:21285-21290.
67. Szymczak, A.L. and Vignali, D.A. 2005. Development of 2A peptide-based strategies in the design of multicistronic vectors. Exp. Opin. Biol. Ther. 5:627-638.
68. Szymczak, A.L.,Workman, C.J.,Wang, Y.,Vignali, K.M., Dilioglou, S., Vanin, E.F., and Vignali, D.A. 2004. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptidebased retroviral vector. Nat. Biotechnol. 22:589- 594.
69. Thyagarajan, B., Guimaraes,M.J., Groth, A.C., and Calos, M.P. 2000. Mammalian genomes contain active recombinase recognition sites. Gene 244:47-54.
70. Thyagarajan, B., Olivares, E.C., Hollis, R.P., Ginsburg, D.S., and Calos, M.P. 2001. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol. Cell Biol. 21:3926-3934.
71. van der Weyden, L., Adams, D.J., and Bradley, A. 2002. Tools for targeted manipulation of the mouse genome. Physiol. Genomics 11:133-164.
72. Wadia, J.S., Stan, R.V., and Dowdy, S.F. 2004. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10:310-315.
73. Wang, Q., Strong, J., and Killeen, N. 2001. Homeostatic competition among T cells revealed by conditional inactivation of the mouse Cd4 gene. J. Exp. Med. 194:1721-1730.
74. Wang, Y., Krushel, L.A., and Edelman, G.M. 1996. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene. Proc. Natl. Acad. Sci. U.S.A. 93:3932- 3936.
75. Xu, Z., Lee, N.C., Dafhnis-Calas, F., Malla, S., Smith, M.C., and Brown, M.R. 2008. Sitespecific recombination in Schizosaccharomyces pombe and systematic assembly of a 400 kb transgene array in mammalian cells using the integrase of Streptomyces phage phiBT1. Nucleic Acids Res. 36:e9.
76. Yagi, R., Junttlia, I.S., Wei, G., Urbahn, J.F. Jr., Zhao, K., Paul, W.E., and Zhu, J. 2010. The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity 32:507-517.
77. Zhu, J., Min, B., Hu-Li, J., Watson, C.J., Grinberg, A., Wang, Q., Killeen, N., Urban, J.F. Jr., Guo, L., and Paul, W.E. 2004. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5:1157- 1165.
78. Zhumabekov, T., Corbella, P., Tolaini, M., and Kioussis, D. 1995. Improved version of a human CD2 minigene based vector for T cellspecific expression in transgenic mice. J. Immunol. Methods 185:133-140.